I am a Senior Research Scientist and R&D leader with expertise in microbiology, immunology, vaccines, and diagnostics. My academic path includes a Ph.D. in Microbiology from Karolinska Institute (Sweden) and postdoctoral training at Dartmouth College and Cornell University (USA). My research focuses on pathogen biology, antibody and antigen discovery, assay development, and vaccine innovation, with over 20 peer-reviewed publications and frequent participation as a Guest Editor and Peer Reviewer for journals such as Vaccines, Pathogens, and Antibodies. I have held senior roles in both academia and industry, including Director of R&D Drug Discovery at Protheragen Inc., lecturer at CEMP, and researcher at IGDORE. I also co-founded a biotech startup in Cambridge, UK, gaining experience in entrepreneurship and translational science. Currently, I am the founder of Biointelix, a biotech startup developing AI-powered bioinformatics tools for protein modeling, docking, vaccine design, immune simulations, and antigenicity prediction. I am also a member of Sigma Xi, The Scientific Research Honor Society (by invitation), and my mission is to advance biomedical discovery through innovation in vaccines, phage therapy, immunotherapy, and diagnostics.